Infectious tolerance

被引:207
作者
Cobbold, S [1 ]
Waldmann, H [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1016/S0952-7915(98)80217-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infectious tolerance can be induced in many ways, does not require a thymus or clonal deletion and can spread to third-party antigens linked on the same antigen-presenting cell the process being variously described as linked-, bystanderor epitope-suppression. We here review the evidence concerning the mechanisms involved and attempt to make a consistent hypothesis, that during tolerance induction in the Th1-mediated autoimmune diseases and transplantation systems there would seem to be a phase of immune deviation towards Th2 cytokines, like IL-4 and IL-10; however, this may lead to an IL-10-induced form of anergy or nonresponsiveness and generation of the recently characterized Th3/T-regulatory-1 CD4(+) cell subset which is thought to downregulate the antigen-presenting cell, possibly via transforming growth factor beta.
引用
收藏
页码:518 / 524
页数:7
相关论文
共 75 条
[1]   A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function [J].
Anderson, DM ;
Maraskovsky, E ;
Billingsley, WL ;
Dougall, WC ;
Tometsko, ME ;
Roux, ER ;
Teepe, MC ;
DuBose, RF ;
Cosman, D ;
Galibert, L .
NATURE, 1997, 390 (6656) :175-179
[2]   ANTI-IL-10 TREATMENT DOES NOT BLOCK EITHER THE INDUCTION OR THE MAINTENANCE OF ORALLY INDUCED TOLERANCE TO OVA [J].
AROEIRA, LS ;
CARDILLO, F ;
DEALBUQUERQUE, DA ;
VAZ, NM ;
MENGEL, J .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 41 (04) :319-323
[3]   Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA [J].
Bai, XF ;
Shi, FD ;
Xiao, BG ;
Li, HL ;
vanderMeide, PH ;
Link, H .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 80 (1-2) :65-75
[4]   Association between alpha beta TCR(+)CD4(-)CD8(-) T-cell deficiency and IDDM in NOD/Lt mice [J].
Baxter, AG ;
Kinder, SJ ;
Hammond, KJL ;
Scollay, R ;
Godfrey, DI .
DIABETES, 1997, 46 (04) :572-582
[5]  
Bemelman F, 1998, J IMMUNOL, V160, P2645
[6]  
Bluestone JA, 1997, J IMMUNOL, V158, P1989
[7]  
BORRIELLO F, 1994, J IMMUNOL, V153, P5038
[8]   Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo [J].
Buer, J ;
Lanoue, A ;
Franzke, A ;
Garcia, C ;
von Boehmer, H ;
Sarukhan, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (02) :177-183
[9]   IN-VIVO DEPLETION OF CD8+ T-CELLS RESULTS IN TH2 CYTOKINE PRODUCTION AND ALTERNATE MECHANISMS OF ALLOGRAFT-REJECTION [J].
CHAN, SY ;
DEBRUYNE, LA ;
GOODMAN, RE ;
EICHWALD, EJ ;
BISHOP, DK .
TRANSPLANTATION, 1995, 59 (08) :1155-1161
[10]   ENHANCED TYPE-2 AND DIMINISHED TYPE-1 CYTOKINES IN NEONATAL TOLERANCE [J].
CHEN, NX ;
FIELD, EH .
TRANSPLANTATION, 1995, 59 (07) :933-941